Decreased CD22 expression and intracellular signaling aberrations in B cells of patients with systemic sclerosis
Rheumatology International Jun 12, 2018
Melissaropoulos K, et al. - In patients with systemic sclerosis (SSc), the phenotype and intracellular signaling events of B cells were explored. Authors examined the levels of intracellular kinases Lyn, Syk and P-Y 348 Syk along with phosphatase SHP-1 with Western immunoblotting in selected patients. In B cells from a small sample of patients, an arithmetic association of low CD22 expression with kinase Lyn underexpression was noted. Results suggested a probable contribution of CD22 underexpression and impaired phosphorylation along with implications for Lyn kinase aberrations in the activated B cell phenotype in SSc.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries